Retractable Technologies (NYSE:RVP) Research Coverage Started at StockNews.com

Analysts at StockNews.com initiated coverage on shares of Retractable Technologies (NYSE:RVP) in a research report issued to clients and investors on Thursday. The firm set a “hold” rating on the stock.

Retractable Technologies Price Performance

Shares of Retractable Technologies stock opened at $1.08 on Thursday. Retractable Technologies has a twelve month low of $0.95 and a twelve month high of $1.85. The company has a quick ratio of 6.41, a current ratio of 8.28 and a debt-to-equity ratio of 0.01. The company has a 50-day simple moving average of $1.19 and a two-hundred day simple moving average of $1.16. The stock has a market capitalization of $32.34 million, a price-to-earnings ratio of -4.50 and a beta of 2.11.

Hedge Funds Weigh In On Retractable Technologies

A hedge fund recently raised its stake in Retractable Technologies stock. WealthTrust Axiom LLC grew its position in Retractable Technologies, Inc. (NYSE:RVP) by 27.8% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 126,533 shares of the company’s stock after buying an additional 27,500 shares during the quarter. WealthTrust Axiom LLC owned 0.42% of Retractable Technologies worth $151,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 7.58% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.